Sopharma AD-Sofia (FRA:3JR) COGS-to-Revenue : 0.77 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia COGS-to-Revenue?

Sopharma AD-Sofia's Cost of Goods Sold for the three months ended in Dec. 2023 was €200.8 Mil. Its Revenue for the three months ended in Dec. 2023 was €259.4 Mil.

Sopharma AD-Sofia's COGS to Revenue for the three months ended in Dec. 2023 was 0.77.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sopharma AD-Sofia's Gross Margin % for the three months ended in Dec. 2023 was 22.61%.

Sopharma AD-Sofia COGS-to-Revenue Historical Data

The historical data trend for Sopharma AD-Sofia's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia COGS-to-Revenue Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.76

0.79

0.78

Sopharma AD-Sofia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.79	0.78	0.77	0.81	0.77

Sopharma AD-Sofia COGS-to-Revenue Calculation

Sopharma AD-Sofia's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	761.836	/	972.369
	=	0.78

Sopharma AD-Sofia's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	200.777	/	259.423
	=	0.77

Sopharma AD-Sofia (FRA:3JR) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sopharma AD-Sofia's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	200.777 / 259.423
	=	22.61 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sopharma AD-Sofia COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (FRA:3JR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SPH:Poland SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines